Cashu
Heron Therapeutics Reports Strong Q4 Growth Amid Expanding Pain Management Market Strategies
11 days ago
Stocks
Health Care
hrtx
Heron Therapeutics
NASDAQ: HRTX
-0.01 (0.00%)
0.9897
USD
At close at Mar 11, 13:26 UTC
Overview
Loading chart...
Key Stats
Market Cap
181.20M
Dividend Yield
0.00%
P/E Ratio
-8.97
EPS
-0.09
Revenue
144.28M
Avg. Volume
2.19M
About
What does HRTX do?
Heron Therapeutics, based in San Diego, develops pharmaceutical products for acute care and oncology, including SUSTOL, CINVANTI, ZYNRELEF, and APONVIE, with 126 employees. Its products are distributed in the U.S.
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.